Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma

Author:

Zheng Yang¹²,Wang Zhao¹³,Ding Xu¹²,Dong Yibo¹²,Zhang Wei¹,Zhang Wei¹⁴,Zhong Yi¹⁴,Gu Wenyi³,Wu Yunong¹²,Song Xiaomeng¹²^ORCID

Affiliation:

1. Key Laboratory of Oral Diseases of Jiangsu Province; Stomatological Institute of Nanjing Medical University; Nanjing China

2. Department of Oral and Maxillofacial Surgery; Affiliated Stomatological Hospital; Nanjing Medical University; Nanjing China

3. Australian Institute for Bioengineering and Nanotechnology; The University of Queensland; Brisbane Qld. Australia

4. Department of Oral Pathology; Affiliated Stomatological Hospital; Nanjing Medical University; Nanjing China

Funder

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

Jiangsu Provincial Medical Innovation Team

Natural Science Foundation of Jiangsu Province

Jiangsu Provincial Medical Youth Talent

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

Reference47 articles.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献